NR is not a panacea, but can it improve muscles, cells and intestinal flora?
We all know that nicotinamide riboside (NR), the precursor of NAD, is a promising compound that can improve obesity-related mitochondrial dysfunction and metabolic syndrome in mice. However, so far, the number of human intervention studies in NR is still relatively small, with the longest clinical trial being 12 weeks, and most short-term clinical trials conducted…